Objective: The aim of this study was to assess clinically the adequacy of vessel-contouringbased pelvic radiotherapy with regard to nodal coverage for uterine cervical cancer. Methods: Fifty patients with Stages I -III cervical cancer, treated with vessel-contouringbased three-dimensional radiotherapy since August 2002, were entered into the study (median age: 54, 47 received concurrent daily cisplatin). All patients were treated with external beam radiotherapy using a four-field box technique with or without brachytherapy. Pelvic blood vessels were identified and contoured on computed tomography simulation images. A generous margin was set outside these vessels outlined on digitally reconstructed radiograph accounting for normal size lymph nodes, patient's motion and set-up uncertainty. Multi-leaf collimator (MLC) was inserted and adjusted manually. Patterns of recurrence were clinically evaluated. Results: Distance between major vessels and MLC edges varied inter-and intra-individually. Median distance in the mid-iliosacral joint level was 25 mm (left) and 24 mm (right). The maximum and the minimum distances ranged from 25 to 45 mm (median, 32) and 9 to 27 mm (median, 15) for left side and 24 to 41 mm (median, 30) and 7 to 28 mm (median, 15) for right side, respectively. With a median follow-up of 43 months, 10 patients developed recurrence. However, no marginal recurrence was occurred just lateral to the contoured vessels. All three patients who developed regional recurrence had recurred at the internal iliac node or the obturator node medial to contoured vessels. Conclusions: Contoured vessels can be used as surrogate markers for location of the pelvic lymph nodes.
INTRODUCTION
Whole pelvic radiotherapy has an essential role in the primary and adjuvant treatment of cervical cancer. However, conventional pelvic field parameters have used bony landmarks to plan pelvic treatment volumes without delineating pelvic nodes in each patient. A four-field box technique has been used as a standard treatment and the lateral extents of the anteroposterior -posteroanterior (AP -PA) portions tended to be defined by the bony pelvis. It has been reported that the treatment planning without using individual patient's clinical target volume (CTV) results in incomplete coverage of the intended target volume for considerable proportion of patients (1 -3) .
Recently, with the advent of diagnostic imaging, individualized nodal locations can be obtained more precisely and it became possible to delineate nodal-CTV around the major pelvic vessels (4) . A guideline for nodal-CTV delineation in patients with cervical/endometrial cancer who undergo post-operative pelvic radiotherapy has already been published (5) . However, the guideline was developed in the setting of intensity-modulated radiotherapy (IMRT), and its clinical applicability is yet to be validated. Since 2002, patients with cervical cancer have been treated with vessel-contouring-based three-dimensional (3D) pelvic radiotherapy in our institution. In the present study, patterns of recurrence were retrospectively analyzed and the adequacy of vessel-contouring-assisted pelvic radiotherapy was clinically assessed with regard to pelvic nodal coverage for patients with uterine cervical cancer. Table 1 . The median age was 54 years (range, 29 -77). Twenty-nine patients were treated with definitive radiotherapy including high-dose-rate brachytherapy and remaining 21 patients were treated with Type III radical hysterectomy and pelvic lymph node dissection followed by post-operative radiotherapy without using vaginal brachytherapy. The histology was squamous cell carcinoma in 40 and adenocarcinoma in 10. FIGO clinical stage of patients treated with definitive radiotherapy was IB1 in 4, IB2 in 3, IIA in 5, IIB in 5, IIIA in 1 and IIIB in 11. Patients who underwent post-operative radiotherapy were IB1 in 13, IB2 in 3, IIA in 1 and IIB in 4. Patients who had multiple para-aortic or high common iliac lymph node metastases detected by computed tomography (CT) before the initiation of the treatment were excluded from the study because these patients were treated with extended field radiotherapy concurrently with the same chemotherapy (6) . Among 21 patients who received postoperative radiotherapy, 6 patients had pathologically confirmed pelvic lymph node metastases, one positive node in 4 and two positive nodes in 2. Forty-seven patients received concurrent low-dose daily cisplatin from the starting day of radiotherapy. Daily cisplatin, at 8 mg/m 2 in 100 ml of normal saline, was administered intravenously over 30 min and was completed 1 h before radiation therapy (7). Post-chemotherapy daily hydration was performed with 1 l of normal saline given over 2 h. Chemotherapy was not delivered during brachytherapy.
PATIENTS AND METHODS

Fifty
For all patients, external beam radiotherapy was delivered using a linear accelerator with a 10 MV photon beam and all patients underwent 3D radiotherapy planning. Patients were positioned on the couch of the CT simulator (AcQSIM, Picker PQ2000 CT, Philips Medical Systems, Andover, MA, USA) in a supine position. CT images were acquired in spiral mode of 1.5 pitch and 3 mm slice thickness during quiet respiration without using intravenous contrast medium. A virtual simulation was performed based on the full 3D-CT anatomical data obtained. The treatment planning and dose distribution calculation with tissue heterogeneity correction were performed using a 3D treatment planning system (FOCUS version 3.2.1 or Xio version 4.3.1, CMS, St Louis, MO, USA). Radiation therapy targets were defined according to the International Commission on Radiation Units and Measurements Report Nos 50 and 62. The gross tumor volume (GTV) consisted of all areas of known gross disease in case of definitive treatment. The CTV included all areas of gross and potentially microscopic disease and included the upper half of the vagina, parametria, uterus if present and regional lymph node regions. Pelvic blood vessels were identified and contoured on every CT simulation images acquired. In our current practice, 7 -10 mm uniform CTV margins for clinically negative pelvic node are added outside these vessels (nodal-CTV), and this is expanded to delineate individualized planning target volume (PTV). However, for patients in this study, we did not expanded contoured vessels uniformly to define nodal-CTV because no consensus as to adequate CTV margin around blood vessels existed during the study period. Instead, each physician sets a generous margin outside these vessels outlined on digitally reconstructed radiograph accounting for normal size lymph nodes (CTV margin), patient's motion and set-up uncertainty. After that, multi-leaf collimator (MLC) was inserted and adjusted manually to shape the lateral border of the AP -PA field considering additional dose uncertainty around MLC edge. In this situation, a distance between major vessels and MLC edges (V -M distance) corresponds to the sum of CTV margin, PTV margin and MLC margin. External beam radiotherapy was delivered conventionally using a four-field box technique with a fractional daily dose of 2.0 Gy at the isocenter to the prescribed total dose of 50 Gy. For 29 patients patients who received post-operative pelvic radiotherapy. In this study, the maximum and the minimum V -M distances between the aortic bifurcation and the femur head level, as well as V -M distance at the midpoint of sacroiliac joint, were retrospectively measured in each patient (Fig. 1) . Recurrent patterns were analyzed and influence of setting lateral field border of AP -PA field (V -M distance) on the patterns of recurrence was clinically investigated. Adequacy of anterior or posterior borders of the lateral field is beyond the scope of the present study. After the completion of radiation therapy, patients were evaluated at 1 -3-month intervals by radiation oncologists and gynecologic oncologists. Radiological studies, serum markers and blood chemistries were ordered at the discretion of the treating oncologists. Regional and/or distant recurrences were mainly diagnosed by CT with or without increment of serum markers. Local recurrences were confirmed by biopsy. All patients gave their written informed consent to the treatment. This study was in accordance with the Declaration of Helsinki (2001).
RESULTS
Measured V -M distance varied inter-and intra-individually. The maximum and the minimum distances, and the distance at the midpoint of sacroiliac joint are shown in Table 2 . The mean and median of maximum V -M distance were 33 mm (SD, 4.4) and 32 mm (range, 24 -45) at the left side and 30 mm (SD, 4.6) and 30 mm (range, 24 -41) at the right side, respectively. Those of minimum V -M distance were 16 mm (SD, 2.4) and 15 mm (range, 9 -27) at the left side and 15 mm (SD, 2.7) and 15 mm (range, 7 -28) at the right side, respectively. The mean and median V -M distance at the midpoint of sacroiliac joint were 25 mm (SD, 4.3) and 25 mm (range, 18 -36) at the left side and 26 mm (SD, 4.9) and 24 mm (range, 17-36) at the right side, respectively.
With a median follow-up of 43 months, 10 patients developed recurrence. Recurrent sites were local in three, regional in three, para-aortic node in two and distant metastasis in three. Of those, one patient experienced simultaneous regional lymph node recurrence and distant metastasis (Table 3 ). All three patients who developed regional recurrence had recurred at the internal iliac node or the obturator node medial to contoured vessels. No marginal recurrence was occurred just lateral to the contoured vessels.
DISCUSSION
Treatment field of whole pelvis for cervical cancer has long been defined by bony pelvic structure. Traditional four-field box technique determined by bony structure has contributed excellent tumor control with acceptable toxicities. However, this technique, without using individual patient's CTV, does not provide a customized treatment planning for each patient and may result in suboptimal nodal-CTV coverage. Bonin et al. (2) and Pendlebury et al. (1) , respectively, reported inadequate coverage of the external iliac lymph nodes using standard irradiation fields in 45% and 62% of patients. Finlay et al. (3) showed that 95% of patients studied had at least one inadequate margin when bony landmarks were used to set the field boundaries. Several clinical studies recommended that 378 Vessel-contouring-based pelvic radiotherapy lateral border of the anterior -posterior (AP) field should be set at 25 -26 mm beyond the widest part of the pelvic brim (1, 2, 8) . It was shown that the coverage of the external iliac nodes was inadequate in 21% of patients if the lateral border of the AP field was placed 2 cm beyond the pelvic brim (3). For radiation oncologists, setting outer boundaries is one of the most concerns in case of radiotherapy using conventional four-field box technique where dose distribution inside the box is relatively uniform. According to the histopathological examination after surgery, the common iliac or the external iliac node metastases are less frequent than the internal iliac or the obturator lymph nodes metastases (9) . Until now, however, little is known concerning the effect of setting lateral margin (nodal-CTV) for the common iliac or the external iliac node area on clinical outcome. The proposed margins around vessels for adequate nodal coverage have changed over time (10 -14). Chao and Lin (11), by using bipedal lymphangiograms, established the distance or relationship between pelvic nodes and the corresponding vessels. To ensure adequate volumetric coverage of the majority of normal-size lymph nodes, they recommended a distance of 15 and 20 mm around the common iliac and external iliac vessels. In their study, larger margins were required to encompass 100% of the lymph nodes identified by lymphangiography. However, lymphangiography using lipiodol for ionizing radiation can increase the apparent size of the nodes (15) . In addition, it seems that the magnetic resonance imaging (MRI) is better able to identify small lymph nodes in pelvis. Taylor et al. (4) used MRI with intravenous injection of iron oxide particles to identify the size and location of pelvic lymph nodes in 20 patients with gynecologic tumors. An average nodal diameter they detected was only 3.8 mm. They advocated a modified 7 mm margin around pelvic vessels as a surrogate target for lymph nodes in pelvic IMRT planning. Based on their MRI-based study, recent consensus guidelines of CTV delineation propose a 7 mm margin around vessels with or without this minor modification (5) . Adequacy of these guidelines will be evaluated prospectively in the RTOG 0418 trial.
Several limitations exist in the present study. We evaluated only lateral borders of AP -PA portions in four-field technique, where the borders depend mainly on the extent of nodal-CTV. It seems necessary to evaluate the appropriateness of other borders in future clinical study. This study included both definitive radiotherapy cases and post-operative radiotherapy cases simultaneously. In the former cases, it is necessary to delineate the GTV and expand it to draw the primary-CTV. If the GTV is bulky, the primary-CTV might contribute the lateral border of AP-PA portions. Fortunately, we have no such case. Because the use of IMRT for gynecologic malignancies has increased recently, a four-field technique is already considered as 'traditional' technique in some institutions. However, under the current medical insurance system, the use of IMRT for gynecological malignancies is not yet approved by the ministry of Health, Labor and Welfare in Japan. Thus, the adequate lateral border of AP -PA portion in four-field technique is still the matter of interest among the radiation oncologists in Japan.
In the clinical practice, organ motion and set-up uncertainty are important considerations with radiotherapy planning. Internal margin and set-up error constitute institution-specific PTV margins. Although no consensus as to PTV margin has been established, a 1.0 -1.5 cm uniform CTV expansion has been commonly advocated. In addition, MLC margin should be accounted for treatment volume. An MLC margin, which means MLC edge location relative to the PTV, depends entirely on the dosimetric aspects of the beams being used for the treatment and the minimum coverage requirements of the prescription. Thus, MLC margin is a treatment-specific value for each patient. In the present study, we evaluate V -M margin which exclusively included nodal-CTV margin, PTV margin and MLC margin. The mean of minimum V -M distance was 16 mm (SD, 2.4) at the left side and 15 mm (SD, 2.7) at the right side, respectively. The mean plus 2SD values of minimum V -M distance correspond to 21 and 20 mm, respectively, for the left and the right side. The median V -M distance at the midpoint of sacroiliac joint was 25 mm in the left side and 24 mm in the right side. Because we have experienced no marginal recurrence lateral to the contoured vessels, 20-25 mm V-M margin can be a practical surrogate for adequate nodal coverage in four-field technique pelvic radiotherapy. Every effort should be made to establish adequate CTV-delineation and margin setting for pelvic radiotherapy in future clinical studies. Simultaneous regional recurrence and distant metastases in one patient.
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